January 31, 2015 8:10 PM ET


Company Overview of Q-RNA, Inc.

Company Overview

Q-RNA, Inc., a biotechnology company, engages in developing molecular biology tools for RNA research, manipulation, amplification, and sequencing. It develops technologies for ribonomics, the functional genomics field that bridges the gap between genomics and proteomics. Q-RNA was formerly known as InVitro Diagnostics, Inc. The company was founded in 1996 and is based in New York, New York. As of November 29, 2006, Q-RNA, Inc. operates as a subsidiary of Neuro-Hitech, Inc.

3960 Broadway

Suite 407

New York, NY 10032

United States

Founded in 1996





Key Executives for Q-RNA, Inc.

Chief Executive Officer and Director
Age: 69
Vice President
Vice President for Product Development
Age: 66
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Amerimmune Pharmaceuticals Inc. United States
Encoded Genomics, Inc. United States
Boval Company, LP United States
Epitomics, Inc. United States
NeuroNascent, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Q-RNA, Inc., please visit www.q-rna.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.